Nipro

Nipro

Nipro Corporation manufactures medical devices, pharmaceuticals and instrument products.

Launch date
Employees
Market cap
AUD2.6b
Enterprise valuation
AUD9.0b (Public information from Sep 2024)
Osaka Osaka Prefecture (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
JPY2021202220232024202520262027
Revenues455.6b494.8b545.2b586.8b635.8b668.3b700.7b
% growth3 %9 %10 %8 %8 %5 %5 %
EBITDA72.9b77.9b68.6b84.9b93.4b99.8b106.1b
% EBITDA margin16 %16 %13 %14 %15 %15 %15 %
Profit14.2b13.5b4.6b11.1b16.5b17.7b19.6b
% profit margin3 %3 %1 %2 %3 %3 %3 %
EV / revenue1.5x1.3x1.2x1.2x1.2x1.1x1.1x
EV / EBITDA9.1x8.2x9.8x8.6x7.9x7.4x7.0x

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
Total Funding-

Recent News about Nipro

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Nipro

Edit
InfraReDx
ACQUISITION by Nipro Oct 2015
ReproCELL
exited